{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T05:26:22Z","timestamp":1772169982624,"version":"3.50.1"},"reference-count":36,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.3892\/etm.2014.1975","type":"journal-article","created":{"date-parts":[[2014,9,17]],"date-time":"2014-09-17T08:37:53Z","timestamp":1410943073000},"page":"1433-1437","source":"Crossref","is-referenced-by-count":17,"title":["Protein tyrosine phosphatase PTPN22 +1858C\/T polymorphism is associated with active vitiligo"],"prefix":"10.3892","volume":"8","author":[{"given":"MARTHA ELENA","family":"GARCIA-MELENDEZ","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MAURICIO","family":"SALINAS-SANTANDER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CELIA","family":"SANCHEZ-DOMINGUEZ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HUGO","family":"GONZALEZ-CARDENAS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RICARDO M.","family":"CERDA-FLORES","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JORGE","family":"OCAMPO-CANDIANI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ROC\u00cdO","family":"ORTIZ-L\u00d3PEZ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2014,9,17]]},"reference":[{"key":"key20180108130750_b1-etm-08-05-1433","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4103\/0378-6323.32708","article-title":"Vitiligo: compendium of clinico-epidemiological features","volume":"73","author":"Sehgal","year":"2007","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"key20180108130750_b2-etm-08-05-1433","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2174\/138920010791526105","article-title":"Vitiligo: pathogenetic hypotheses and targets for current therapies","volume":"11","author":"Guerra","year":"2010","journal-title":"Curr Drug Metab"},{"key":"key20180108130750_b3-etm-08-05-1433","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1590\/S0365-05962004000300010","article-title":"Vitiligo","volume":"79","author":"Steiner","year":"2004","journal-title":"An Bras Dermatol"},{"key":"key20180108130750_b4-etm-08-05-1433","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1477-7525-1-58","article-title":"Quality of life in patients with vitiligo","volume":"1","author":"Parsad","year":"2003","journal-title":"Health Qual Life Outcomes"},{"key":"key20180108130750_b5-etm-08-05-1433","unstructured":"MorettiSVitiligo: Orphanet EncyclopediaOctober2003http:\/\/www.orpha.net\/data\/patho\/GB\/uk-vitiligo.pdfAccessed December 13, 2013"},{"key":"key20180108130750_b6-etm-08-05-1433","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4103\/0378-6323.19730","article-title":"Vitiligo: a sign of systemic disease","volume":"72","author":"Huggins","year":"2006","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"key20180108130750_b7-etm-08-05-1433","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa061592","article-title":"NALP1 in vitiligo-associated multiple autoimmune disease","volume":"356","author":"Jin","year":"2007","journal-title":"N Engl J Med"},{"key":"key20180108130750_b8-etm-08-05-1433","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/jdv.12169","article-title":"Clinical profile of generalized vitiligo patients with associated autoimmune\/autoinflammatory diseases","volume":"28","author":"van Gell","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key20180108130750_b9-etm-08-05-1433","first-page":"526","article-title":"Vitiligo: pathomechanisms and genetic polymorphism of susceptible genes","volume":"44","author":"Shajil","year":"2006","journal-title":"Indian J Exp Biol"},{"key":"key20180108130750_b10-etm-08-05-1433","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.autrev.2006.09.010","article-title":"Autoantibody responses to melanocytes in the depigmenting skin disease vitiligo","volume":"6","author":"Kemp","year":"2007","journal-title":"Autoimmun Rev"},{"key":"key20180108130750_b11-etm-08-05-1433","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0001-7310(05)73058-1","article-title":"Vitiligo. Treatment of 12 cases with topical tacrolimus","volume":"96","author":"Almeida","year":"2005","journal-title":"Actas Dermosifiliogr"},{"key":"key20180108130750_b12-etm-08-05-1433","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-4632.2009.03852.x","article-title":"Efficacy and safety of tarcrolimus cream 0.1% in the treatment of vitiligo","volume":"48","author":"Xu","year":"2009","journal-title":"Int J Dermatol"},{"key":"key20180108130750_b13-etm-08-05-1433","doi-asserted-by":"crossref","first-page":"J254","DOI":"10.1016\/j.jaut.2011.12.001","article-title":"Sex differences and genomics in autoimmune diseases","volume":"38","author":"Amur","year":"2012","journal-title":"J Autoimmun"},{"key":"key20180108130750_b14-etm-08-05-1433","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1182\/blood.V93.6.2013.406k25_2013_2024","article-title":"Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp","volume":"93","author":"Cohen","year":"1999","journal-title":"Blood"},{"key":"key20180108130750_b15-etm-08-05-1433","doi-asserted-by":"crossref","first-page":"368","DOI":"10.18632\/aging.100305","article-title":"Association of PTPN22 1858T\/T genotype with type 1 diabetes, Graves\u2019 disease but not with rheumatoid arthritis in Russian population","volume":"3","author":"Zhebrun","year":"2011","journal-title":"Aging (Albany NY)"},{"key":"key20180108130750_b16-etm-08-05-1433","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.imlet.2012.05.007","article-title":"The +1858C\/T PTPN22 gene polymorphism confers genetic susceptibility to rheumatoid arthritis in Mexican population from the Western Mexico","volume":"147","author":"Torres-Carrillo","year":"2012","journal-title":"Immunol Lett"},{"key":"key20180108130750_b17-etm-08-05-1433","first-page":"638","article-title":"Lack of association between the protein tyrosine phosphatase non-receptor type 22 R263Q and R620W functional genetic variants and endogenous non-anterior uveitis","volume":"19","author":"C\u00e9nit","year":"2013","journal-title":"Mol Vis"},{"key":"key20180108130750_b18-etm-08-05-1433","doi-asserted-by":"crossref","first-page":"7861","DOI":"10.1007\/s11033-012-1630-z","article-title":"PTPN22 C1858T and the risk of psoriasis: a meta-analysis","volume":"39","author":"Chen","year":"2012","journal-title":"Mol Biol Rep"},{"key":"key20180108130750_b19-etm-08-05-1433","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ng1323","article-title":"A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes","volume":"36","author":"Bottini","year":"2004","journal-title":"Nat Genet"},{"key":"key20180108130750_b20-etm-08-05-1433","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/sj.gene.6364243","article-title":"A single-nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptibility to generalised vitiligo","volume":"6","author":"Cant\u00f3n","year":"2005","journal-title":"Genes Immun"},{"key":"key20180108130750_b21-etm-08-05-1433","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/08916930701464897","article-title":"Protein tyrosine phosphatase PTPN22 in human autoimmunity","volume":"40","author":"Vang","year":"2007","journal-title":"Autoimmunity"},{"key":"key20180108130750_b22-etm-08-05-1433","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.4049\/jimmunol.0803317","article-title":"PTPN22 deficiency cooperates with the CD45 E613R allele to break tolerance on a nonautoimmune background","volume":"182","author":"Zikherman","year":"2009","journal-title":"J Immunol"},{"key":"key20180108130750_b23-etm-08-05-1433","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1755-148X.2008.00443.x","article-title":"The PTPN22-1858C>T (R620W) functional polymorphism is associated with generalized vitiligo in the Romanian population","volume":"21","author":"Laberge","year":"2008","journal-title":"Pigment Cell Melanoma Res"},{"key":"key20180108130750_b24-etm-08-05-1433","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/sj.gene.6364350","article-title":"Association analysis of the PTPN22 gene in childhood-onset systemic lupus erythematosus in Mexican population","volume":"7","author":"Baca","year":"2006","journal-title":"Genes Immun"},{"key":"key20180108130750_b25-etm-08-05-1433","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/rheumatology\/kei250","article-title":"Effects of PTPN22 C1858T polymorphism on susceptibility and clinical characteristics of British Caucasian rheumatoid arthritis patients","volume":"45","author":"Harrison","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"key20180108130750_b26-etm-08-05-1433","first-page":"333","article-title":"Origin of normal and malignant melanocytes","volume":"43","author":"Aris","year":"2009","journal-title":"Acta Bioqu\u00edm Cl\u00edn Latinoam"},{"key":"key20180108130750_b27-etm-08-05-1433","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jdermsci.2005.06.004","article-title":"The genetic concept of vitiligo","volume":"39","author":"Zhang","year":"2005","journal-title":"J Dermatol Sci"},{"key":"key20180108130750_b28-etm-08-05-1433","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.autrev.2011.02.004","article-title":"Immunopathogenesis of vitiligo","volume":"10","author":"Sandoval-Cruz","year":"2011","journal-title":"Autoimmun Rev"},{"key":"key20180108130750_b29-etm-08-05-1433","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4103\/0974-2077.112667","article-title":"Stability in vitiligo: Is there a perfect way to predict it?","volume":"6","author":"Sahni","year":"2013","journal-title":"J Cutan Aesthet Surg"},{"key":"key20180108130750_b30-etm-08-05-1433","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1600-0749.2007.00384.x","article-title":"The genetics of generalized vitiligo and associated autoimmune diseases","volume":"20","author":"Spritz","year":"2007","journal-title":"Pigment Cell Res"},{"key":"key20180108130750_b31-etm-08-05-1433","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1016\/j.febslet.2011.04.032","article-title":"Why is PTPN22 a good candidate susceptibility gene for autoimmune disease?","volume":"585","author":"Burn","year":"2011","journal-title":"FEBS Lett"},{"key":"key20180108130750_b32-etm-08-05-1433","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/ng.904","article-title":"The autoimmune disease-associated PTPN22 variant promotes calpain-mediated Lyp\/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness","volume":"43","author":"Zhang","year":"2011","journal-title":"Nat Genet"},{"key":"key20180108130750_b33-etm-08-05-1433","doi-asserted-by":"crossref","first-page":"e18907","DOI":"10.1371\/journal.pone.0018907","article-title":"Th17 cells and activated dendritic cells are increased in vitiligo lesions","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS One"},{"key":"key20180108130750_b34-etm-08-05-1433","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3109\/08916930903405883","article-title":"Allele and haplotype frequency distribution in PTPN22 gene across variable ethnic groups: Implications for genetic association studies for autoimmune diseases","volume":"43","author":"Lins","year":"2010","journal-title":"Autoimmunity"},{"key":"key20180108130750_b35-etm-08-05-1433","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00580-012-1508-4","article-title":"PTPN22 gene polymorphism in Egyptian females with non-segmental vitiligo","volume":"22","author":"Elmongy","year":"2013","journal-title":"Comp Clin Pathol"},{"key":"key20180108130750_b36-etm-08-05-1433","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1007\/s11033-012-2370-9","article-title":"The CTLA-4 +49 A\/G, CT60 A\/G and PTPN22 1858 C\/T polymorphisms and susceptibility to vitiligo: a meta-analysis","volume":"40","author":"Song","year":"2013","journal-title":"Mol Biol Rep"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/etm.2014.1975\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T14:42:51Z","timestamp":1598280171000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2014.1975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,17]]},"references-count":36,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,9,17]]},"published-print":{"date-parts":[[2014,11]]}},"alternative-id":["10.3892\/etm.2014.1975"],"URL":"https:\/\/doi.org\/10.3892\/etm.2014.1975","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,17]]}}}